XML 28 R16.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue
3 Months Ended
Apr. 30, 2025
Revenues [Abstract]  
Revenue Revenue
Disaggregation of Revenue
The Company believes that the nature, amount, timing and uncertainty of its revenue and cash flows and how they are affected by economic factors is most appropriately depicted through the Company’s primary geographical markets and subscription product categories. The Company’s primary geographical markets are North and South America (“Americas”); Europe, Middle East and Africa (“EMEA”); and Asia Pacific. The Company also disaggregates its subscription products between its MongoDB Atlas-related offerings and other subscription products, which include MongoDB Enterprise Advanced.
The following table presents the Company’s revenues disaggregated by primary geographical markets, subscription product categories and services (in thousands):
Three Months Ended April 30,
20252024
Primary geographical markets:
Americas
$332,867 $272,093 
EMEA
150,766 123,296 
Asia Pacific
65,381 55,172 
Total
$549,014 $450,561 
Subscription product categories and services:
MongoDB Atlas-related
$395,893 $313,855 
Other subscription
135,562 123,041 
Services
17,559 13,665 
Total
$549,014 $450,561 
Contract Liabilities
The Company’s contract liabilities are recorded as deferred revenue in the Company’s condensed consolidated balance sheets and consist of customer invoices issued or payments received in advance of revenues being recognized from the Company’s subscription and services contracts. Deferred revenue, including current and non-current balances, as of April 30, 2025 and January 31, 2025 was $320.1 million and $359.8 million, respectively. Approximately 24% and 33% of the total revenue recognized for the three months ended April 30, 2025 and 2024, respectively, was from deferred revenue at the beginning of each respective period.
Remaining Performance Obligations
Remaining performance obligations represent the aggregate amount of the transaction price in contracts allocated to performance obligations not delivered, or partially undelivered, as of the end of the reporting period. Remaining performance obligations include unearned revenue, multi-year contracts with future installment payments and certain unfulfilled orders against accepted customer contracts at the end of any given period. As of April 30, 2025, the aggregate transaction price allocated to remaining performance obligations was $774.3 million. Approximately 58% is expected to be recognized as revenue over the next 12 months 38% in 13 to 36 months and the remainder thereafter. The Company applies the practical expedient to omit disclosure with respect to the amount of the transaction price allocated to remaining performance obligations if the related contract has a total duration of 12 months or less.
Unbilled Receivables
Revenue recognized in excess of invoiced amounts creates an unbilled receivable, which represents the Company’s unconditional right to consideration in exchange for goods or services that the Company has transferred to the customer. Unbilled receivables are recorded as part of accounts receivable, net in the Company’s condensed consolidated balance sheets. As of April 30, 2025 and January 31, 2025, unbilled receivables were $30.6 million and $22.5 million, respectively.
Allowance for Doubtful Accounts
The Company considers expectations of forward-looking losses, in addition to historical loss rates, to estimate its allowance for doubtful accounts on its accounts receivable. The following is a summary of the changes in the Company’s allowance for doubtful accounts (in thousands):
Allowance for Doubtful Accounts
Balance at January 31, 2025
$8,888 
Provision3,289 
Recoveries/write-offs(2,284)
Balance as of April 30, 2025
$9,893 
Costs Capitalized to Obtain Contracts with Customers
Deferred commissions were $355.6 million and $363.4 million as of April 30, 2025 and January 31, 2025, respectively, of which $239.3 million and $250.7 million comprised the non-current portion and was included in other assets on the Company’s consolidated balance sheets as of April 30, 2025 and January 31, 2025, respectively. Amortization expense with respect to deferred commissions, which is included in sales and marketing expense in the Company’s interim condensed consolidated statements of operations, was $31.2 million and $26.4 million for the three months ended April 30, 2025, and 2024, respectively. There was no impairment loss in relation to the costs capitalized for the periods presented.